GLYC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.70%

Insider Buying (Last 12 Months): $95,800.00

Insider Selling (Last 12 Months): $0.00

GlycoMimetics Insider Trading History Chart

GlycoMimetics Share Price & Price History

^$0.24

▲ +0.01 (4.33%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

625,000% Gain

From Crypto Swap Profits | Ad

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

GlycoMimetics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/20/2024	Edwin Rock	Insider	Buy	190,000	$0.25	$47,500.00	565,403
9/21/2023	Edwin Rock	Insider	Buy	35,000	$1.38	$48,300.00	345,000
5/17/2023	Brian M Hahn	CFO	Sell	3,700	$1.95	$7,215.00	53,143
5/10/2023	Daniel M Junius	Director	Buy	30,000	$1.56	$46,800.00	93,250
5/8/2023	Bruce S Johnson	SVP	Buy	13,500	$1.57	$21,195.00	138,980
2/23/2023	Public Equities L.P. Invus	Major Shareholder	Buy	200,000	$1.75	$350,000.00	8,489,064
2/21/2023	Public Equities L.P. Invus	Major Shareholder	Buy	50,000	$1.85	$92,500.00	8,139,064
2/17/2023	Public Equities L.P. Invus	Major Shareholder	Buy	200,000	$1.71	$342,000.00	8,089,064
2/15/2023	Public Equities L.P. Invus	Major Shareholder	Buy	1,000,000	$2.16	$2,160,000.00	7,573,798
2/9/2023	Public Equities L.P. Invus	Major Shareholder	Buy	11,451	$3.24	$37,101.24	6,573,798
1/25/2023	Scott D Sandell	Major Shareholder	Sell	652,016	$3.26	$2,125,572.16	3,588,288
1/5/2023	Scott D Sandell	Major Shareholder	Sell	71,362	$2.76	$196,959.12	3,881,933
1/3/2023	Scott D Sandell	Major Shareholder	Sell	174,814	$2.99	$522,693.86	3,960,002
12/22/2022	Edwin Rock	Insider	Buy	110,000	$2.25	$247,500.00	310,000
11/14/2022	Edwin Rock	Insider	Buy	100,000	$1.43	$143,000.00	100,000
3/9/2022	Brian M Hahn	CFO	Sell	2,917	$1.09	$3,179.53
3/9/2022	John L Magnani	SVP	Sell	3,227	$1.09	$3,517.43
11/16/2021	Patricia S. Andrews	Director	Buy	40,000	$2.05	$82,000.00

J.P. Morgan’s DIRE Warning

From Behind the Markets | Ad

When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."

Click here to see why Wall Street is in PANIC mode >>>

SEC Filings (Institutional Ownership Changes) for GlycoMimetics (NASDAQ:GLYC)

75.19% of GlycoMimetics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

GlycoMimetics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/15/2024	NEA Management Company LLC	3,835,039	$11.51M	0.7%	-19.5%	5.949%
5/10/2024	Acadian Asset Management LLC	330,526	$0.99M	0.0%	-38.9%	0.513%
5/10/2024	Vanguard Group Inc.	2,761,981	$8.29M	0.0%	+14.0%	4.285%
2/8/2024	Advisor OS LLC	101,000	$0.24M	0.0%	N/A	0.157%
2/5/2024	Intellectus Partners LLC	50,720	$0.12M	0.0%	-18.2%	0.079%
1/18/2024	MJP Associates Inc. ADV	101,000	$0.24M	0.1%	N/A	0.157%
11/15/2023	Acuta Capital Partners LLC	27,500	$41K	0.0%	N/A	0.043%
11/13/2023	Acadian Asset Management LLC	844,051	$1.27M	0.0%	-26.6%	1.311%
11/13/2023	Sargent Investment Group LLC	58,000	$87K	0.0%	-46.3%	0.090%
10/25/2023	Intellectus Partners LLC	61,975	$93K	0.0%	-15.7%	0.096%
8/7/2023	Acadian Asset Management LLC	1,149,656	$2M	0.0%	-18.0%	1.788%
7/31/2023	Intellectus Partners LLC	73,475	$0.13M	0.0%	-10.1%	0.114%
7/18/2023	Stratos Wealth Partners LTD.	33,340	$58K	0.0%	-67.5%	0.052%
5/11/2023	Letko Brosseau & Associates Inc.	45,250	$57K	0.0%	N/A	0.070%
5/11/2023	Acadian Asset Management LLC	1,401,653	$1.77M	0.0%	-27.9%	2.182%
5/10/2023	Beirne Wealth Consulting Services LLC	50,000	$63K	0.0%	+25.0%	0.078%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	159,001	$0.20M	0.0%	+143.5%	0.247%
5/5/2023	Truist Financial Corp	101,000	$0.13M	0.0%	N/A	0.157%
5/2/2023	Sargent Investment Group LLC	108,000	$0.14M	0.0%	N/A	0.168%
4/27/2023	Stratos Wealth Partners LTD.	102,565	$0.13M	0.0%	N/A	0.160%
4/26/2023	Chicago Partners Investment Group LLC	20,000	$28K	0.0%	N/A	0.031%
2/15/2023	Freedom Wealth Alliance LLC	9,452	$29K	0.0%	N/A	0.018%
2/10/2023	NEA Management Company LLC	8,967,706	$27.17M	1.5%	-1.3%	17.107%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	65,288	$0.20M	0.0%	N/A	0.125%
2/8/2023	Beirne Wealth Consulting Services LLC	40,000	$0.12M	0.1%	N/A	0.076%
2/2/2023	Intellectus Partners LLC	81,730	$0.25M	0.1%	-32.2%	0.156%
1/31/2023	AE Wealth Management LLC	26,898	$82K	0.0%	N/A	0.051%
5/12/2022	Acadian Asset Management LLC	1,990,087	$2.27M	0.0%	+2.0%	3.798%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	89,926	$0.10M	0.0%	-24.7%	0.172%
2/14/2022	Eversept Partners LP	100,000	$0.14M	0.0%	N/A	0.193%
2/14/2022	GSA Capital Partners LLP	146,078	$0.21M	0.0%	N/A	0.282%
2/10/2022	Acadian Asset Management LLC	1,951,086	$2.81M	0.0%	+3.4%	3.771%
11/16/2021	Two Sigma Advisers LP	621,000	$1.36M	0.0%	-12.4%	1.200%
11/16/2021	Two Sigma Investments LP	498,530	$1.09M	0.0%	+121.0%	0.964%
11/15/2021	Dimensional Fund Advisors LP	904,628	$1.98M	0.0%	-23.3%	1.748%
11/15/2021	Franklin Resources Inc.	160,700	$0.35M	0.0%	N/A	0.311%
11/12/2021	Renaissance Technologies LLC	596,100	$1.31M	0.0%	-21.3%	1.152%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	112,298	$0.25M	0.0%	+5.5%	0.217%
11/9/2021	BlackRock Inc.	875,151	$1.92M	0.0%	-1.2%	1.691%
8/17/2021	Millennium Management LLC	686,577	$1.59M	0.0%	+1,284.5%	1.332%
8/17/2021	Bridgeway Capital Management LLC	215,700	$0.50M	0.0%	+26.4%	0.419%
8/16/2021	Squarepoint Ops LLC	16,216	$38K	0.0%	N/A	0.031%
8/16/2021	AQR Capital Management LLC	97,590	$0.23M	0.0%	-54.0%	0.189%
8/16/2021	LMR Partners LLP	22,889	$53K	0.0%	N/A	0.044%
8/16/2021	Charles Schwab Investment Management Inc.	11,422	$27K	0.0%	-87.0%	0.022%
8/16/2021	State Street Corp	144,265	$0.34M	0.0%	-77.9%	0.280%
8/16/2021	Tibra Equities Europe Ltd	136,100	$0.32M	0.1%	N/A	0.264%
8/16/2021	Goldman Sachs Group Inc.	123,407	$0.29M	0.0%	+253.3%	0.239%
8/13/2021	Renaissance Technologies LLC	757,693	$1.76M	0.0%	+20.9%	1.470%
8/13/2021	Northern Trust Corp	108,713	$0.25M	0.0%	-71.8%	0.211%
8/13/2021	Intellectus Partners LLC	123,000	$0.29M	0.1%	+51.9%	0.239%
8/13/2021	Jump Financial LLC	18,000	$42K	0.0%	N/A	0.035%
8/13/2021	QS Investors LLC	160,700	$0.37M	0.0%	+58.3%	0.312%
8/13/2021	Qube Research & Technologies Ltd	14,488	$34K	0.0%	N/A	0.028%
8/13/2021	Geode Capital Management LLC	352,740	$0.82M	0.0%	-51.0%	0.684%
8/13/2021	Vanguard Group Inc.	2,270,457	$5.27M	0.0%	-14.6%	4.405%
8/12/2021	XTX Topco Ltd	58,992	$0.14M	0.0%	N/A	0.114%
8/12/2021	Dimensional Fund Advisors LP	1,178,938	$2.74M	0.0%	-2.9%	2.287%
8/12/2021	Advisory Services Network LLC	35,800	$83K	0.0%	N/A	0.069%
8/12/2021	JPMorgan Chase & Co.	263,914	$0.61M	0.0%	+4.6%	0.512%
8/12/2021	Ergoteles LLC	160,900	$0.37M	0.0%	N/A	0.312%
8/12/2021	Connor Clark & Lunn Investment Management Ltd.	106,442	$0.25M	0.0%	-16.8%	0.207%
8/11/2021	Bank of New York Mellon Corp	26,664	$62K	0.0%	-80.4%	0.052%
8/11/2021	BlackRock Inc.	886,148	$2.06M	0.0%	-68.6%	1.719%
8/11/2021	Susquehanna Fundamental Investments LLC	144,717	$0.34M	0.0%	+268.2%	0.281%
5/18/2021	Millennium Management LLC	49,591	$0.15M	0.0%	-77.7%	0.096%
5/18/2021	D. E. Shaw & Co. Inc.	515,898	$1.55M	0.0%	-10.7%	1.001%
5/18/2021	Cubist Systematic Strategies LLC	26,900	$81K	0.0%	+62.4%	0.052%
5/18/2021	Man Group plc	27,900	$84K	0.0%	-51.1%	0.054%
5/18/2021	Jane Street Group LLC	11,543	$35K	0.0%	N/A	0.022%
5/17/2021	PDT Partners LLC	82,300	$0.25M	0.0%	+59.5%	0.160%
5/17/2021	AQR Capital Management LLC	212,088	$0.64M	0.0%	N/A	0.412%
5/17/2021	Intellectus Partners LLC	81,000	$0.24M	0.1%	+710.0%	0.157%
5/17/2021	Nuveen Asset Management LLC	1,059,121	$3.19M	0.0%	+171.2%	2.055%
5/17/2021	Goldman Sachs Group Inc.	34,930	$0.11M	0.0%	-30.8%	0.068%
5/14/2021	Dimensional Fund Advisors LP	1,214,587	$3.66M	0.0%	+0.5%	2.357%
5/13/2021	QS Investors LLC	101,500	$0.31M	0.0%	N/A	0.197%
5/13/2021	ClariVest Asset Management LLC	168,800	$0.51M	0.0%	+29.8%	0.328%
5/13/2021	Barclays PLC	31,020	$93K	0.0%	+158.4%	0.060%
5/13/2021	Renaissance Technologies LLC	626,500	$1.89M	0.0%	-12.5%	1.216%
5/13/2021	Bank of New York Mellon Corp	136,337	$0.41M	0.0%	+3.1%	0.265%
5/13/2021	Federated Hermes Inc.	342,631	$1.03M	0.0%	-17.0%	0.665%
5/12/2021	Northern Trust Corp	385,772	$1.16M	0.0%	-10.8%	0.749%
5/12/2021	Geode Capital Management LLC	720,179	$2.17M	0.0%	+7.0%	1.397%
5/12/2021	JPMorgan Chase & Co.	252,200	$0.76M	0.0%	+24.4%	0.489%
5/12/2021	Panagora Asset Management Inc.	65,061	$0.20M	0.0%	-38.7%	0.126%
5/12/2021	UBS Group AG	27,454	$83K	0.0%	-53.5%	0.053%
5/11/2021	Acadian Asset Management LLC	1,645,295	$4.95M	0.0%	+103.2%	3.192%
5/7/2021	BlackRock Inc.	2,823,587	$8.50M	0.0%	+7.9%	5.479%
5/7/2021	BNP Paribas Arbitrage SA	15,071	$45K	0.0%	+113.6%	0.029%
5/4/2021	Commonwealth Equity Services LLC	10,000	$30K	0.0%	N/A	0.019%
5/4/2021	Ieq Capital LLC	38,363	$0.12M	0.0%	N/A	0.074%
3/8/2021	Dimensional Fund Advisors LP	1,208,120	$4.54M	0.0%	+0.9%	2.346%
2/25/2021	Dimensional Fund Advisors LP	1,208,120	$4.54M	0.0%	+0.9%	2.526%
2/24/2021	Virtu Financial LLC	12,826	$48K	0.0%	N/A	0.027%
2/19/2021	JPMorgan Chase & Co.	202,776	$0.76M	0.0%	+171.9%	0.424%
2/18/2021	Intellectus Partners LLC	10,000	$38K	0.0%	N/A	0.021%
2/16/2021	Squarepoint Ops LLC	39,862	$0.15M	0.0%	+25.5%	0.083%
2/16/2021	LMR Partners LLP	10,527	$40K	0.0%	-30.0%	0.022%
2/16/2021	Nuveen Asset Management LLC	390,594	$1.47M	0.0%	+14.1%	0.817%

Data available starting January 2016

GlycoMimetics, Inc., a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the United States. It develops uproleselan, an E-selectin antagonist, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as completed phase 3 trial to treat relapsed/refractory AML. The company also develops various other programs, including GMI-1687, an antagonist of E-selectin to treat vaso-occlusive crisis; and GMI-2093, a galectin-3 carbohydrate-binding protein. In addition, its portfolio comprises GMI-1359, which targets e-selectin and a chemokine receptor for the treatment of osteosarcoma. The company has a cooperative research and development agreement with the National Cancer Institute; and a collaboration and license agreement with Apollomics (Hong Kong) Limited for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland.

Today's Range

Now: $0.24

$0.23

$0.25

50 Day Range

MA: $0.28

$0.24

$0.33

52 Week Range

Now: $0.24

$0.20

$3.53

Volume

1,448,004 shs

Average Volume

2,248,770 shs

Market Capitalization

$15.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.19

Who are the company insiders with the largest holdings of GlycoMimetics?: GlycoMimetics' top insider shareholders include:
Public Equities LP Invus (Major Shareholder)
Scott D Sandell (Major Shareholder)
Edwin Rock (Insider)
Bruce S Johnson (SVP)
Daniel M Junius (Director)
Brian M Hahn (CFO)
Learn More about top insider investors at GlycoMimetics.